Coronary artery disease Posts on Medivizor
Navigation Menu

Coronary artery disease Posts on Medivizor

Does an invasive approach benefit patients with stable coronary disease when compared to a conservative approach?

Does an invasive approach benefit patients with stable coronary disease when compared to a conservative approach?

Posted by on Jun 27, 2020 in Coronary artery disease | 0 comments

In a nutshell The study assessed whether an initial invasive strategy (IS) for treating stable coronary artery disease (CAD) in patients with moderate or severe ischemia (reduced blood supply to the heart) have a better outcome when compared to a conservative strategy (CS). The study concluded that over the course of 3.2 years, invasive...

Read More

Is an anti-clotting injection selatogrel effective for patients suffering from heart attacks?

Is an anti-clotting injection selatogrel effective for patients suffering from heart attacks?

Posted by on Jun 22, 2020 in Coronary artery disease | 0 comments

In a nutshell This study examined how fast and effective a dose of an anti-clotting injection, selatogrel, was for patients suffering from heart attacks. The authors found that both doses were effective by 30 minutes, but the high dose worked faster. Some background At the beginning of a heart attack, patients should be given anti-clotting...

Read More

Does Xinyue capsule, a Chinese herbal medicine, reduce the risk of cardiovascular events?

Does Xinyue capsule, a Chinese herbal medicine, reduce the risk of cardiovascular events?

Posted by on Jun 19, 2020 in Coronary artery disease | 0 comments

In a nutshell This study investigated if the Xinyue capsule (XYC) reduces the risk of cardiovascular events (CVEs) in patients with coronary artery disease (CAD).  They found that XYC combined with standard treatment reduced the risk of CVEs in these patients.  Some background Coronary artery disease (CAD) is caused by blockages in...

Read More

Does air pollution reduce the effectiveness of exercise for patients with heart disease?

Does air pollution reduce the effectiveness of exercise for patients with heart disease?

Posted by on Jun 13, 2020 in Coronary artery disease | 0 comments

In a nutshell This study examined if high air pollution reduced the effectiveness of exercise for patients with heart disease. The authors found that moderate to intense exercise reduced patients’ risks of heart disease and strokes regardless of air pollution. Some background Exercise is one way that patients can reduce their risks of heart...

Read More

Antiplatelet therapy in patients aged 70 or older with acute coronary syndrome

Antiplatelet therapy in patients aged 70 or older with acute coronary syndrome

Posted by on Jun 11, 2020 in Coronary artery disease | 0 comments

In a nutshell This study investigated antiplatelet therapy (APT) in patients aged 70 or older with acute coronary syndrome (ACS). They found that clopidogrel (Plavix) was associated with fewer bleeding events (BEs) in these patients. Some background Acute coronary syndrome (ACS) is caused by reduced blood flow to the heart. ACS can...

Read More

Does ticagrelor alone reduce bleeding risk after percutaneous coronary intervention?

Posted by on May 9, 2020 in Coronary artery disease | 0 comments

In a nutshell This study investigated the effect of ticagrelor (Brilique) with or without aspirin after a percutaneous coronary intervention (PCI). They found that ticagrelor alone reduced bleeding risk after PCI. Some background Coronary artery disease (CAD) is caused by blockages in the coronary arteries. This reduces blood flow...

Read More

Dual antiplatelet therapy to prevent cardiovascular events: is a combination of rivaroxaban and aspirin safe and effective after PCI?

Posted by on Apr 21, 2020 in Coronary artery disease | 0 comments

In a nutshell This study investigated the effectiveness of dual antiplatelet therapy (DAPT) with rivaroxaban (Xarelto) and aspirin in patients with a history of percutaneous coronary intervention (PCI).  They found that DAPT with rivaroxaban and aspirin reduced major adverse cardiac events (MACE) but increased bleeding risk (BR)...

Read More

How effective are bioresorbable scaffolds to treat patients with coronary artery disease?

Posted by on Apr 18, 2020 in Coronary artery disease | 0 comments

In a nutshell This study examined how effective bioresorbable scaffolds (BRS) were at preventing heart complications in patients with coronary artery disease (CAD). The study found that while BRS were somewhat effective, some patients still developed complications. Some background CAD is caused by the narrowing of blood vessels in the heart....

Read More

Which drug improves blood flow and reduces inflammation after stent insertion in patients with heart disease?

Posted by on Mar 28, 2020 in Coronary artery disease | 0 comments

In a nutshell This study compared three drugs to see which was better at improving blood flow and reducing inflammation after patients with heart disease were given a stent. The results showed that prasugrel (Efient) improved patients’ blood flow more than clopidogrel (Plavix) or ticagrelor (Brilique). Some background Heart disease,...

Read More

Ticagrelor vs. prasugrel – which is more effective as a maintenance treatment after a heart attack?

Posted by on Mar 19, 2020 in Coronary artery disease | 0 comments

In a nutshell This study compared ticagrelor (Brilique) and prasugrel (Efient) as a maintenance antiplatelet therapy (APT) after a myocardial infarction (MI; heart attack). They found that ticagrelor had a better APT effect and fewer bleeding events. Some background Coronary artery disease (CAD) is a condition that leads to...

Read More

Percutaneous coronary intervention vs. coronary artery bypass graft – a review of 5 year outcomes

Posted by on Feb 25, 2020 in Coronary artery disease | 0 comments

In a nutshell This study investigated the long-term outcomes of percutaneous coronary intervention (PCI) compared to coronary artery bypass surgery (CABG) in patients with blockages in the left main coronary artery. They found that PCI was less effective than CABG in these patients. Some background Coronary artery disease (CAD) is caused by...

Read More